JP2009524677A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009524677A5 JP2009524677A5 JP2008552423A JP2008552423A JP2009524677A5 JP 2009524677 A5 JP2009524677 A5 JP 2009524677A5 JP 2008552423 A JP2008552423 A JP 2008552423A JP 2008552423 A JP2008552423 A JP 2008552423A JP 2009524677 A5 JP2009524677 A5 JP 2009524677A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- phenyl
- thiazol
- trifluoromethyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 -OR 4 Chemical group 0.000 claims 63
- 150000001875 compounds Chemical class 0.000 claims 51
- 125000001072 heteroaryl group Chemical group 0.000 claims 39
- 125000000623 heterocyclic group Chemical group 0.000 claims 34
- 125000003107 substituted aryl group Chemical group 0.000 claims 33
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 29
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 28
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 28
- 125000003710 aryl alkyl group Chemical group 0.000 claims 27
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 27
- 125000000547 substituted alkyl group Chemical group 0.000 claims 27
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 27
- 125000005843 halogen group Chemical group 0.000 claims 26
- 125000000217 alkyl group Chemical group 0.000 claims 23
- 125000004093 cyano group Chemical group *C#N 0.000 claims 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 16
- 125000001309 chloro group Chemical group Cl* 0.000 claims 13
- 125000001424 substituent group Chemical group 0.000 claims 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 12
- 125000001188 haloalkyl group Chemical group 0.000 claims 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 12
- 125000004438 haloalkoxy group Chemical group 0.000 claims 9
- 125000001246 bromo group Chemical group Br* 0.000 claims 8
- 125000001153 fluoro group Chemical group F* 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 8
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 claims 7
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 125000004076 pyridyl group Chemical group 0.000 claims 5
- AVRQBXVUUXHRMY-UHFFFAOYSA-N 2,6-difluorobenzamide Chemical compound NC(=O)C1=C(F)C=CC=C1F AVRQBXVUUXHRMY-UHFFFAOYSA-N 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims 4
- 125000002971 oxazolyl group Chemical group 0.000 claims 4
- 125000000335 thiazolyl group Chemical group 0.000 claims 4
- 125000002757 morpholinyl group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 125000003831 tetrazolyl group Chemical group 0.000 claims 3
- DTNSDCJFTHMDAK-UHFFFAOYSA-N 2-cyanobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C#N DTNSDCJFTHMDAK-UHFFFAOYSA-N 0.000 claims 2
- QMDMUIQZTHZWGH-UHFFFAOYSA-N 3-methylpyridine-4-carboxamide Chemical compound CC1=CN=CC=C1C(N)=O QMDMUIQZTHZWGH-UHFFFAOYSA-N 0.000 claims 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 230000005931 immune cell recruitment Effects 0.000 claims 2
- 230000003834 intracellular effect Effects 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- PUQWWUNZUBYOMY-UHFFFAOYSA-N n-[4-(2,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound COC1=CC=C(OC)C(C=2N=C(NC(=O)C=3C(=CC=CC=3F)F)SC=2)=C1 PUQWWUNZUBYOMY-UHFFFAOYSA-N 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 claims 2
- ARECGWDLHRTHRH-UHFFFAOYSA-N 2,6-difluoro-n-(4-methyl-5-pyridin-3-yl-1,3-thiazol-2-yl)benzamide Chemical compound S1C(C=2C=NC=CC=2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F ARECGWDLHRTHRH-UHFFFAOYSA-N 0.000 claims 1
- JOYAMVVOHQJMBI-UHFFFAOYSA-N 2,6-difluoro-n-(4-methyl-5-pyridin-4-yl-1,3-thiazol-2-yl)benzamide Chemical compound S1C(C=2C=CN=CC=2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F JOYAMVVOHQJMBI-UHFFFAOYSA-N 0.000 claims 1
- AXYZEFQWLFAGRI-UHFFFAOYSA-N 2,6-difluoro-n-(4-methyl-5-pyridin-4-yl-1,3-thiazol-2-yl)benzamide;hydrobromide Chemical compound Br.S1C(C=2C=CN=CC=2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F AXYZEFQWLFAGRI-UHFFFAOYSA-N 0.000 claims 1
- YRHNHMMVGLICDU-UHFFFAOYSA-N 2,6-difluoro-n-(4-methyl-5-thiophen-2-yl-1,3-thiazol-2-yl)benzamide Chemical compound S1C(C=2SC=CC=2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F YRHNHMMVGLICDU-UHFFFAOYSA-N 0.000 claims 1
- XRCGNECSKSISBL-UHFFFAOYSA-N 2,6-difluoro-n-(4-methyl-5-thiophen-3-yl-1,3-thiazol-2-yl)benzamide Chemical compound S1C(C2=CSC=C2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F XRCGNECSKSISBL-UHFFFAOYSA-N 0.000 claims 1
- JHIRFISORPMPSQ-UHFFFAOYSA-N 2,6-difluoro-n-[4-(1,2-oxazol-3-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C2=NOC=C2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 JHIRFISORPMPSQ-UHFFFAOYSA-N 0.000 claims 1
- LMUZEDUQLAAFLT-UHFFFAOYSA-N 2,6-difluoro-n-[4-(1,3,4-oxadiazol-2-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C=2OC=NN=2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 LMUZEDUQLAAFLT-UHFFFAOYSA-N 0.000 claims 1
- NYZMPLCWTQKRJK-UHFFFAOYSA-N 2,6-difluoro-n-[4-(1,3-oxazol-5-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C=2OC=NC=2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 NYZMPLCWTQKRJK-UHFFFAOYSA-N 0.000 claims 1
- OSYUTNVAYBPRQG-UHFFFAOYSA-N 2,6-difluoro-n-[4-(1-hydroxyethyl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C(O)C)N=C1NC(=O)C1=C(F)C=CC=C1F OSYUTNVAYBPRQG-UHFFFAOYSA-N 0.000 claims 1
- MWSMKQPENXMRNB-UHFFFAOYSA-N 2,6-difluoro-n-[4-(1h-imidazol-2-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide;hydrochloride Chemical compound Cl.FC1=CC=CC(F)=C1C(=O)NC1=NC(C=2NC=CN=2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 MWSMKQPENXMRNB-UHFFFAOYSA-N 0.000 claims 1
- RINXDLOPSAGXNS-UHFFFAOYSA-N 2,6-difluoro-n-[4-(1h-pyrazol-5-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C2=NNC=C2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 RINXDLOPSAGXNS-UHFFFAOYSA-N 0.000 claims 1
- XVZZUSSPILKGTJ-UHFFFAOYSA-N 2,6-difluoro-n-[4-(2-hydroxypropan-2-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C(C)(O)C)N=C1NC(=O)C1=C(F)C=CC=C1F XVZZUSSPILKGTJ-UHFFFAOYSA-N 0.000 claims 1
- OREDVPGFICXHDS-UHFFFAOYSA-N 2,6-difluoro-n-[4-(2-methyl-1,3-thiazol-4-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C)=NC(C2=C(SC(NC(=O)C=3C(=CC=CC=3F)F)=N2)C=2C=C(C=CC=2)C(F)(F)F)=C1 OREDVPGFICXHDS-UHFFFAOYSA-N 0.000 claims 1
- OOHKSGRPWCFEIV-UHFFFAOYSA-N 2,6-difluoro-n-[4-(3-methylimidazol-4-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound CN1C=NC=C1C1=C(C=2C=C(C=CC=2)C(F)(F)F)SC(NC(=O)C=2C(=CC=CC=2F)F)=N1 OOHKSGRPWCFEIV-UHFFFAOYSA-N 0.000 claims 1
- LZHYDQVOZYXEBH-UHFFFAOYSA-N 2,6-difluoro-n-[4-(6-methylpyridin-2-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound CC1=CC=CC(C2=C(SC(NC(=O)C=3C(=CC=CC=3F)F)=N2)C=2C=C(C=CC=2)C(F)(F)F)=N1 LZHYDQVOZYXEBH-UHFFFAOYSA-N 0.000 claims 1
- WDPQDLYETMXUBA-UHFFFAOYSA-N 2,6-difluoro-n-[4-(hydroxymethyl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(CO)N=C1NC(=O)C1=C(F)C=CC=C1F WDPQDLYETMXUBA-UHFFFAOYSA-N 0.000 claims 1
- KHNUXYCJONMJPC-UHFFFAOYSA-N 2,6-difluoro-n-[4-formyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C=O)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 KHNUXYCJONMJPC-UHFFFAOYSA-N 0.000 claims 1
- RYWJFQAHCQBFOE-UHFFFAOYSA-N 2,6-difluoro-n-[4-methyl-5-(2-methyl-1,3-thiazol-4-yl)-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C)=NC(C2=C(N=C(NC(=O)C=3C(=CC=CC=3F)F)S2)C)=C1 RYWJFQAHCQBFOE-UHFFFAOYSA-N 0.000 claims 1
- QNAAZCJHKQTXGO-UHFFFAOYSA-N 2,6-difluoro-n-[4-methyl-5-(2-morpholin-4-ylpyridin-4-yl)-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=C(N=CC=2)N2CCOCC2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F QNAAZCJHKQTXGO-UHFFFAOYSA-N 0.000 claims 1
- CJHJMVFQKWSVPD-UHFFFAOYSA-N 2,6-difluoro-n-[4-methyl-5-(4-nitrophenyl)-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=CC(=CC=2)[N+]([O-])=O)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F CJHJMVFQKWSVPD-UHFFFAOYSA-N 0.000 claims 1
- VKWISXSRLNKHAP-UHFFFAOYSA-N 2,6-difluoro-n-[4-methyl-5-[2-methyl-5-(1,3-oxazol-2-yl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C(=CC=C(C=2)C=2OC=CN=2)C)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F VKWISXSRLNKHAP-UHFFFAOYSA-N 0.000 claims 1
- KUFHKPXEKORDRF-UHFFFAOYSA-N 2,6-difluoro-n-[4-methyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F KUFHKPXEKORDRF-UHFFFAOYSA-N 0.000 claims 1
- POVLMKLRFYNORH-UHFFFAOYSA-N 2,6-difluoro-n-[4-prop-1-en-2-yl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C(=C)C)N=C1NC(=O)C1=C(F)C=CC=C1F POVLMKLRFYNORH-UHFFFAOYSA-N 0.000 claims 1
- SBNYOJBOUCAOSB-UHFFFAOYSA-N 2,6-difluoro-n-[4-propan-2-yl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C(C)C)N=C1NC(=O)C1=C(F)C=CC=C1F SBNYOJBOUCAOSB-UHFFFAOYSA-N 0.000 claims 1
- KOUDCCLVTRPYIQ-UHFFFAOYSA-N 2,6-difluoro-n-[4-propanoyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C(=O)CC)N=C1NC(=O)C1=C(F)C=CC=C1F KOUDCCLVTRPYIQ-UHFFFAOYSA-N 0.000 claims 1
- WKDNRYIACMZTMZ-UHFFFAOYSA-N 2,6-difluoro-n-[4-pyridin-2-yl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C=2N=CC=CC=2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 WKDNRYIACMZTMZ-UHFFFAOYSA-N 0.000 claims 1
- JBYIMZRICHWBEA-UHFFFAOYSA-N 2,6-difluoro-n-[5-(3-fluorophenyl)-4-(hydroxymethyl)-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C=2C=C(F)C=CC=2)=C(CO)N=C1NC(=O)C1=C(F)C=CC=C1F JBYIMZRICHWBEA-UHFFFAOYSA-N 0.000 claims 1
- RROCJKPOZXZHNE-UHFFFAOYSA-N 2,6-difluoro-n-[5-[2-prop-2-enoxy-5-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC=C(C=2C(=CC=C(C=2)C(F)(F)F)OCC=C)S1 RROCJKPOZXZHNE-UHFFFAOYSA-N 0.000 claims 1
- IMZJBQQCIJHXAQ-UHFFFAOYSA-N 2,6-difluoro-n-[5-[3-(2-methyltetrazol-5-yl)phenyl]-1,3-thiazol-2-yl]benzamide Chemical compound CN1N=NC(C=2C=C(C=CC=2)C=2SC(NC(=O)C=3C(=CC=CC=3F)F)=NC=2)=N1 IMZJBQQCIJHXAQ-UHFFFAOYSA-N 0.000 claims 1
- WOSKFRFJQRMKJA-UHFFFAOYSA-N 2,6-difluoro-n-[5-[3-(trifluoromethyl)phenyl]-4-(5-trimethylsilyl-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]benzamide Chemical compound O1C([Si](C)(C)C)=CC(C2=C(SC(NC(=O)C=3C(=CC=CC=3F)F)=N2)C=2C=C(C=CC=2)C(F)(F)F)=N1 WOSKFRFJQRMKJA-UHFFFAOYSA-N 0.000 claims 1
- ODUZJBKKYBQIBX-UHFFFAOYSA-N 2,6-difluoroaniline Chemical compound NC1=C(F)C=CC=C1F ODUZJBKKYBQIBX-UHFFFAOYSA-N 0.000 claims 1
- IZJWUQPWWWQLQX-UHFFFAOYSA-N 2-[(2,6-difluorobenzoyl)amino]-5-[3-(trifluoromethyl)phenyl]-1,3-thiazole-4-carboxylic acid Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C(=O)O)N=C1NC(=O)C1=C(F)C=CC=C1F IZJWUQPWWWQLQX-UHFFFAOYSA-N 0.000 claims 1
- XFLYGKSPECTGIP-UHFFFAOYSA-N 2-[2-chloro-5-(trifluoromethyl)phenyl]-n-(2,6-difluorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound CC=1N=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)SC=1C(=O)NC1=C(F)C=CC=C1F XFLYGKSPECTGIP-UHFFFAOYSA-N 0.000 claims 1
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 claims 1
- WLAOZKAHMXLQFY-UHFFFAOYSA-N 3-fluoro-n-[4-methyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyridine-4-carboxamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C)N=C1NC(=O)C1=CC=NC=C1F WLAOZKAHMXLQFY-UHFFFAOYSA-N 0.000 claims 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 1
- UNOBSGYLZJUXDJ-UHFFFAOYSA-N 3-methyl-n-(4-methyl-5-pyridin-4-yl-1,3-thiazol-2-yl)pyridine-4-carboxamide Chemical compound S1C(C=2C=CN=CC=2)=C(C)N=C1NC(=O)C1=CC=NC=C1C UNOBSGYLZJUXDJ-UHFFFAOYSA-N 0.000 claims 1
- IYYAXYFQKKSHSX-UHFFFAOYSA-N 3-methyl-n-[4-methyl-5-(4-nitrophenyl)-1,3-thiazol-2-yl]pyridine-4-carboxamide Chemical compound S1C(C=2C=CC(=CC=2)[N+]([O-])=O)=C(C)N=C1NC(=O)C1=CC=NC=C1C IYYAXYFQKKSHSX-UHFFFAOYSA-N 0.000 claims 1
- FHAOWTQICJXLCH-UHFFFAOYSA-N 3-methyl-n-[4-methyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyridine-4-carboxamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C)N=C1NC(=O)C1=CC=NC=C1C FHAOWTQICJXLCH-UHFFFAOYSA-N 0.000 claims 1
- HKGANQPELRXKPH-UHFFFAOYSA-N 4-methyl-n-[4-methyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]thiadiazole-5-carboxamide Chemical compound N1=NSC(C(=O)NC=2SC(=C(C)N=2)C=2C=C(C=CC=2)C(F)(F)F)=C1C HKGANQPELRXKPH-UHFFFAOYSA-N 0.000 claims 1
- PTVNFIPMUFCMIY-UHFFFAOYSA-N 5-[2-chloro-5-(trifluoromethyl)phenyl]-n-(2,6-difluorophenyl)-4-methyl-1,3-thiazole-2-carboxamide Chemical compound CC=1N=C(C(=O)NC=2C(=CC=CC=2F)F)SC=1C1=CC(C(F)(F)F)=CC=C1Cl PTVNFIPMUFCMIY-UHFFFAOYSA-N 0.000 claims 1
- SCJPAZKOYPVFRT-UHFFFAOYSA-N 5-[2-chloro-5-(trifluoromethyl)phenyl]-n-(3-methylpyridin-4-yl)-1,3-thiazole-2-carboxamide Chemical compound CC1=CN=CC=C1NC(=O)C1=NC=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)S1 SCJPAZKOYPVFRT-UHFFFAOYSA-N 0.000 claims 1
- 102000004310 Ion Channels Human genes 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 125000005336 allyloxy group Chemical group 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 230000016396 cytokine production Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- OJENZBBDWGSYIQ-UHFFFAOYSA-N ethyl 4-[2-[(2,6-difluorobenzoyl)amino]-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]-5-methyl-1,3-thiazole-2-carboxylate Chemical compound S1C(C(=O)OCC)=NC(C2=C(SC(NC(=O)C=3C(=CC=CC=3F)F)=N2)C=2C=C(C=CC=2)C(F)(F)F)=C1C OJENZBBDWGSYIQ-UHFFFAOYSA-N 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 1
- 230000004968 inflammatory condition Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- FKBHMHFOZOFWLT-UHFFFAOYSA-N methyl 2-[(2,6-difluorobenzoyl)amino]-5-(3-methoxyphenyl)-1,3-thiazole-4-carboxylate Chemical compound S1C(C=2C=C(OC)C=CC=2)=C(C(=O)OC)N=C1NC(=O)C1=C(F)C=CC=C1F FKBHMHFOZOFWLT-UHFFFAOYSA-N 0.000 claims 1
- JNYSAFDNFKBOSV-UHFFFAOYSA-N methyl 2-[(2,6-difluorobenzoyl)amino]-5-[2-prop-2-enoxy-5-(trifluoromethyl)phenyl]-1,3-thiazole-4-carboxylate Chemical compound S1C(C=2C(=CC=C(C=2)C(F)(F)F)OCC=C)=C(C(=O)OC)N=C1NC(=O)C1=C(F)C=CC=C1F JNYSAFDNFKBOSV-UHFFFAOYSA-N 0.000 claims 1
- KKQKKSSVBCUQPM-UHFFFAOYSA-N methyl 2-[(2,6-difluorobenzoyl)amino]-5-[3-(trifluoromethyl)phenyl]-1,3-thiazole-4-carboxylate Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C(=O)OC)N=C1NC(=O)C1=C(F)C=CC=C1F KKQKKSSVBCUQPM-UHFFFAOYSA-N 0.000 claims 1
- OTWZTUCHGGLLSA-UHFFFAOYSA-N methyl 3-[2-[(2,6-difluorobenzoyl)amino]-4-methyl-1,3-thiazol-5-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(N=C(NC(=O)C=3C(=CC=CC=3F)F)S2)C)=C1 OTWZTUCHGGLLSA-UHFFFAOYSA-N 0.000 claims 1
- QHACIPXGPQFIKF-UHFFFAOYSA-N n-(2,6-difluorophenyl)-4-methyl-5-[3-(1,3,4-oxadiazol-2-yl)phenyl]-1,3-thiazole-2-carboxamide Chemical compound CC=1N=C(C(=O)NC=2C(=CC=CC=2F)F)SC=1C(C=1)=CC=CC=1C1=NN=CO1 QHACIPXGPQFIKF-UHFFFAOYSA-N 0.000 claims 1
- MPPWPOQZDGGEQT-UHFFFAOYSA-N n-[(2,6-difluorophenyl)methyl]-4-methyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C)N=C1NCC1=C(F)C=CC=C1F MPPWPOQZDGGEQT-UHFFFAOYSA-N 0.000 claims 1
- HJSDVGSZOUHMHW-UHFFFAOYSA-N n-[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CS1 HJSDVGSZOUHMHW-UHFFFAOYSA-N 0.000 claims 1
- GHWIFWNGXKKHRQ-UHFFFAOYSA-N n-[4-(2,4-dimethyl-1,3-oxazol-5-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound O1C(C)=NC(C)=C1C1=C(C=2C=C(C=CC=2)C(F)(F)F)SC(NC(=O)C=2C(=CC=CC=2F)F)=N1 GHWIFWNGXKKHRQ-UHFFFAOYSA-N 0.000 claims 1
- CLZHQVFQHIUZLD-UHFFFAOYSA-N n-[4-(2,5-dimethyl-1,3-thiazol-4-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C)=NC(C2=C(SC(NC(=O)C=3C(=CC=CC=3F)F)=N2)C=2C=C(C=CC=2)C(F)(F)F)=C1C CLZHQVFQHIUZLD-UHFFFAOYSA-N 0.000 claims 1
- MOEQXMVEEHRNSP-UHFFFAOYSA-N n-[4-(2-amino-1,3-thiazol-4-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(N)=NC(C2=C(SC(NC(=O)C=3C(=CC=CC=3F)F)=N2)C=2C=C(C=CC=2)C(F)(F)F)=C1 MOEQXMVEEHRNSP-UHFFFAOYSA-N 0.000 claims 1
- NGMPCBBGTDPNJA-UHFFFAOYSA-N n-[4-(2-bromoacetyl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C(=O)CBr)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 NGMPCBBGTDPNJA-UHFFFAOYSA-N 0.000 claims 1
- ATOOTUUEXSMODA-UHFFFAOYSA-N n-[4-(3,4-dimethoxyphenyl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C=2C=C(C=CC=2)C(F)(F)F)SC(NC(=O)C=2C(=CC=CC=2F)F)=N1 ATOOTUUEXSMODA-UHFFFAOYSA-N 0.000 claims 1
- PAGANBXATYFCTF-UHFFFAOYSA-N n-[4-(4,5-dihydro-1,3-oxazol-2-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C=2OCCN=2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 PAGANBXATYFCTF-UHFFFAOYSA-N 0.000 claims 1
- DVWZFYUJIJOMAU-UHFFFAOYSA-N n-[4-(4,5-dihydro-1h-imidazol-2-yl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C=2NCCN=2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 DVWZFYUJIJOMAU-UHFFFAOYSA-N 0.000 claims 1
- WYAROCQKDHIRBZ-UHFFFAOYSA-N n-[4-(chloromethyl)-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(CCl)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 WYAROCQKDHIRBZ-UHFFFAOYSA-N 0.000 claims 1
- ADUXGSRJWAACCF-UHFFFAOYSA-N n-[4-[(dimethylamino)methyl]-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(CN(C)C)N=C1NC(=O)C1=C(F)C=CC=C1F ADUXGSRJWAACCF-UHFFFAOYSA-N 0.000 claims 1
- DPOXBSFZICYHBU-UHFFFAOYSA-N n-[4-[4-(dimethylamino)phenyl]-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound C1=CC(N(C)C)=CC=C1C1=C(C=2C=C(C=CC=2)C(F)(F)F)SC(NC(=O)C=2C(=CC=CC=2F)F)=N1 DPOXBSFZICYHBU-UHFFFAOYSA-N 0.000 claims 1
- CTQZGJIKHFKHMN-UHFFFAOYSA-N n-[4-acetyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C(=O)C)N=C1NC(=O)C1=C(F)C=CC=C1F CTQZGJIKHFKHMN-UHFFFAOYSA-N 0.000 claims 1
- RXFOILPYBNWCIE-UHFFFAOYSA-N n-[4-amino-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(N)N=C1NC(=O)C1=C(F)C=CC=C1F RXFOILPYBNWCIE-UHFFFAOYSA-N 0.000 claims 1
- AOYDHSCFPDWSFT-UHFFFAOYSA-N n-[4-chloro-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(Cl)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 AOYDHSCFPDWSFT-UHFFFAOYSA-N 0.000 claims 1
- OOPHTDZEMSMIEU-UHFFFAOYSA-N n-[4-cyano-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C#N)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 OOPHTDZEMSMIEU-UHFFFAOYSA-N 0.000 claims 1
- ULKHOEUPZDRAII-UHFFFAOYSA-N n-[4-cyclopropyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C2CC2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 ULKHOEUPZDRAII-UHFFFAOYSA-N 0.000 claims 1
- FXPXNKOOZOQPPT-UHFFFAOYSA-N n-[4-cyclopropyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-3-methylpyridine-4-carboxamide Chemical compound CC1=CN=CC=C1C(=O)NC1=NC(C2CC2)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 FXPXNKOOZOQPPT-UHFFFAOYSA-N 0.000 claims 1
- JDDNBJDXADBIJY-UHFFFAOYSA-N n-[4-ethenyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C=C)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 JDDNBJDXADBIJY-UHFFFAOYSA-N 0.000 claims 1
- ZRSZMDCTSHJHLX-UHFFFAOYSA-N n-[4-ethyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(CC)N=C1NC(=O)C1=C(F)C=CC=C1F ZRSZMDCTSHJHLX-UHFFFAOYSA-N 0.000 claims 1
- HJFXFMQZSITWTM-UHFFFAOYSA-N n-[4-ethynyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC(C#C)=C(C=2C=C(C=CC=2)C(F)(F)F)S1 HJFXFMQZSITWTM-UHFFFAOYSA-N 0.000 claims 1
- LTWAXZUUICFIJX-UHFFFAOYSA-N n-[5-(2,5-dibromothiophen-3-yl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C2=C(SC(Br)=C2)Br)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F LTWAXZUUICFIJX-UHFFFAOYSA-N 0.000 claims 1
- PZAQVTNPEIPHJZ-UHFFFAOYSA-N n-[5-(2,5-dimethoxyphenyl)-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound COC1=CC=C(OC)C(C=2SC(NC(=O)C=3C(=CC=CC=3F)F)=NC=2)=C1 PZAQVTNPEIPHJZ-UHFFFAOYSA-N 0.000 claims 1
- AOZJRFYPYSNXLN-UHFFFAOYSA-N n-[5-(2,5-dimethoxyphenyl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound COC1=CC=C(OC)C(C2=C(N=C(NC(=O)C=3C(=CC=CC=3F)F)S2)C)=C1 AOZJRFYPYSNXLN-UHFFFAOYSA-N 0.000 claims 1
- LNNQQBQEZYQADQ-UHFFFAOYSA-N n-[5-(2,5-dimethylcyclohexen-1-yl)-1,3-thiazol-2-yl]-3-methylpyridine-4-carboxamide Chemical compound C1C(C)CCC(C)=C1C(S1)=CN=C1NC(=O)C1=CC=NC=C1C LNNQQBQEZYQADQ-UHFFFAOYSA-N 0.000 claims 1
- BDHPUOMUSDUSIC-UHFFFAOYSA-N n-[5-(2-bromo-4,5-dimethoxyphenyl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound C1=C(OC)C(OC)=CC(Br)=C1C1=C(C)N=C(NC(=O)C=2C(=CC=CC=2F)F)S1 BDHPUOMUSDUSIC-UHFFFAOYSA-N 0.000 claims 1
- QPUIXRJRQHUCDM-UHFFFAOYSA-N n-[5-(2-bromo-5-methoxyphenyl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound COC1=CC=C(Br)C(C2=C(N=C(NC(=O)C=3C(=CC=CC=3F)F)S2)C)=C1 QPUIXRJRQHUCDM-UHFFFAOYSA-N 0.000 claims 1
- HASANRVKGSSJEU-UHFFFAOYSA-N n-[5-(2-bromopyridin-4-yl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2C=C(Br)N=CC=2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F HASANRVKGSSJEU-UHFFFAOYSA-N 0.000 claims 1
- PEGUEQBFWKQFMO-UHFFFAOYSA-N n-[5-(2-cyanopyridin-4-yl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2C=C(N=CC=2)C#N)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F PEGUEQBFWKQFMO-UHFFFAOYSA-N 0.000 claims 1
- PVHZIASAHQCHBD-UHFFFAOYSA-N n-[5-(3,4-dimethoxyphenyl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(C)N=C(NC(=O)C=2C(=CC=CC=2F)F)S1 PVHZIASAHQCHBD-UHFFFAOYSA-N 0.000 claims 1
- DTIKDGOJUZCYHB-UHFFFAOYSA-N n-[5-(3-cyanophenyl)-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC=C(C=2C=C(C=CC=2)C#N)S1 DTIKDGOJUZCYHB-UHFFFAOYSA-N 0.000 claims 1
- WEBIYSDQKPNOKD-UHFFFAOYSA-N n-[5-(3-cyanophenyl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2C=C(C=CC=2)C#N)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F WEBIYSDQKPNOKD-UHFFFAOYSA-N 0.000 claims 1
- PAQGXAZFZGYWLX-UHFFFAOYSA-N n-[5-(4-chloropyridin-2-yl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2N=CC=C(Cl)C=2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F PAQGXAZFZGYWLX-UHFFFAOYSA-N 0.000 claims 1
- BKLCIZQQRGIQBZ-UHFFFAOYSA-N n-[5-(4-chloropyridin-2-yl)-4-methyl-1,3-thiazol-2-yl]-3-methylpyridine-4-carboxamide;hydrochloride Chemical compound Cl.S1C(C=2N=CC=C(Cl)C=2)=C(C)N=C1NC(=O)C1=CC=NC=C1C BKLCIZQQRGIQBZ-UHFFFAOYSA-N 0.000 claims 1
- GNMHWICCICZVAN-UHFFFAOYSA-N n-[5-(5-bromothiophen-2-yl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2SC(Br)=CC=2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F GNMHWICCICZVAN-UHFFFAOYSA-N 0.000 claims 1
- KVXFLFROOBMUGT-UHFFFAOYSA-N n-[5-(7-bromo-1,3-benzodioxol-5-yl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2C=C(Br)C=3OCOC=3C=2)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F KVXFLFROOBMUGT-UHFFFAOYSA-N 0.000 claims 1
- ZGQUIBYTJLLUPE-UHFFFAOYSA-N n-[5-(7-cyano-1,3-benzodioxol-5-yl)-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound S1C(C=2C=C(C=3OCOC=3C=2)C#N)=C(C)N=C1NC(=O)C1=C(F)C=CC=C1F ZGQUIBYTJLLUPE-UHFFFAOYSA-N 0.000 claims 1
- QJYLREOKBQKMTO-UHFFFAOYSA-N n-[5-[2-chloro-5-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NN=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)S1 QJYLREOKBQKMTO-UHFFFAOYSA-N 0.000 claims 1
- YCEVANSKDGKSIN-UHFFFAOYSA-N n-[5-[2-chloro-5-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=NC=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)S1 YCEVANSKDGKSIN-UHFFFAOYSA-N 0.000 claims 1
- WKPSQKLBNOMUMS-UHFFFAOYSA-N n-[5-[4-(dimethylamino)phenyl]-4-methyl-1,3-thiazol-2-yl]-2,6-difluorobenzamide Chemical compound C1=CC(N(C)C)=CC=C1C1=C(C)N=C(NC(=O)C=2C(=CC=CC=2F)F)S1 WKPSQKLBNOMUMS-UHFFFAOYSA-N 0.000 claims 1
- JJUHBUKWNCYFHU-UHFFFAOYSA-N n-[5-[4-(dimethylamino)phenyl]-4-methyl-1,3-thiazol-2-yl]-3-methylpyridine-4-carboxamide Chemical compound C1=CC(N(C)C)=CC=C1C1=C(C)N=C(NC(=O)C=2C(=CN=CC=2)C)S1 JJUHBUKWNCYFHU-UHFFFAOYSA-N 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims 1
- 150000002790 naphthalenes Chemical class 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- WQRBOENCMVUGFG-UHFFFAOYSA-M sodium;(2,6-difluorobenzoyl)-[4-methyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]azanide Chemical compound [Na+].S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C)N=C1[N-]C(=O)C1=C(F)C=CC=C1F WQRBOENCMVUGFG-UHFFFAOYSA-M 0.000 claims 1
- MXTFDIZITLYYSU-UHFFFAOYSA-M sodium;(3-methylpyridine-4-carbonyl)-[4-methyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]azanide Chemical compound [Na+].S1C(C=2C=C(C=CC=2)C(F)(F)F)=C(C)N=C1[N-]C(=O)C1=CC=NC=C1C MXTFDIZITLYYSU-UHFFFAOYSA-M 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- GGNIKGLUPSHSBV-UHFFFAOYSA-N thiazole-5-carboxamide Chemical compound NC(=O)C1=CN=CS1 GGNIKGLUPSHSBV-UHFFFAOYSA-N 0.000 claims 1
- 150000003557 thiazoles Chemical class 0.000 claims 1
- 0 CC(CCC(*)=C1)=C1c([s]1)c(*)nc1I* Chemical compound CC(CCC(*)=C1)=C1c([s]1)c(*)nc1I* 0.000 description 7
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76193306P | 2006-01-25 | 2006-01-25 | |
| US76197406P | 2006-01-25 | 2006-01-25 | |
| PCT/US2007/002121 WO2007087427A2 (en) | 2006-01-25 | 2007-01-25 | Thiazole and thiadiazole compounds for inflammation and immune-related uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009524677A JP2009524677A (ja) | 2009-07-02 |
| JP2009524677A5 true JP2009524677A5 (https=) | 2010-03-11 |
Family
ID=38309864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552423A Pending JP2009524677A (ja) | 2006-01-25 | 2007-01-25 | 炎症および免疫関連使用用のチアゾールおよびチアジアゾール化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8455658B2 (https=) |
| EP (1) | EP1983980A4 (https=) |
| JP (1) | JP2009524677A (https=) |
| AU (1) | AU2007208225B2 (https=) |
| CA (1) | CA2639910A1 (https=) |
| TW (1) | TWI444370B (https=) |
| WO (1) | WO2007087427A2 (https=) |
Families Citing this family (112)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100406567C (zh) * | 2002-01-22 | 2008-07-30 | 生物材料公司 | 生物可降解聚合物的干燥方法 |
| TW200806290A (en) * | 2006-01-25 | 2008-02-01 | Synta Pharmaceuticals Corp | Substituted biaryl compounds for inflammation and immune-related uses |
| US7816535B2 (en) | 2006-01-25 | 2010-10-19 | Synta Pharmaceuticals Corp. | Vinyl-phenyl derivatives for inflammation and immune-related uses |
| WO2007087429A2 (en) * | 2006-01-25 | 2007-08-02 | Synta Pharmaceuticals Corp. | Phenyl and pyridyl compounds for inflammation and immune-related uses |
| TW200806641A (en) * | 2006-01-25 | 2008-02-01 | Synta Pharmaceuticals Corp | Substituted aromatic compounds for inflammation and immune-related uses |
| AU2007227210A1 (en) | 2006-03-20 | 2007-09-27 | Synta Pharmaceuticals Corp. | Benzoimidazolyl-parazine compounds for inflammation and immune-related uses |
| US8779154B2 (en) * | 2006-09-26 | 2014-07-15 | Qinglin Che | Fused ring compounds for inflammation and immune-related uses |
| EP2192838A4 (en) | 2007-08-15 | 2011-07-27 | Harvard College | HETEROCYCLIC NEKROPTOSIS HEMMER |
| US8263641B2 (en) * | 2007-09-10 | 2012-09-11 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US8389567B2 (en) * | 2007-12-12 | 2013-03-05 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US20110052643A1 (en) * | 2008-01-07 | 2011-03-03 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| TWI392673B (zh) | 2008-08-27 | 2013-04-11 | Calcimedica Inc | 調控細胞內鈣離子濃度之化合物 |
| US8536185B2 (en) | 2008-09-22 | 2013-09-17 | Cayman Chemical Company, Incorporated | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases |
| US8524763B2 (en) * | 2008-09-22 | 2013-09-03 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| US8143269B2 (en) * | 2008-10-03 | 2012-03-27 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| UA107791C2 (en) | 2009-05-05 | 2015-02-25 | Dow Agrosciences Llc | Pesticidal compositions |
| EP2477982A4 (en) * | 2009-09-16 | 2013-04-03 | Calcimedica Inc | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM |
| EP2305660A1 (en) * | 2009-09-25 | 2011-04-06 | Almirall, S.A. | New thiadiazole derivatives |
| US8377970B2 (en) | 2009-10-08 | 2013-02-19 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel |
| US8993612B2 (en) | 2009-10-08 | 2015-03-31 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| EP2563759B1 (en) | 2010-04-27 | 2022-04-06 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US10703722B2 (en) | 2010-04-27 | 2020-07-07 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| JP6112486B2 (ja) | 2010-04-27 | 2017-04-12 | カルシメディカ，インク． | 細胞内カルシウムを調節する化合物 |
| EP2568809A4 (en) | 2010-05-12 | 2013-11-06 | Univ Vanderbilt | HETEROCYCLIC ALLOSTERE SULFON MGLUR4 POTENTIATORS, COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTIONS |
| NZ604831A (en) * | 2010-07-02 | 2014-12-24 | Gilead Sciences Inc | Apoptosis signal-regulating kinase inhibitors |
| EP2609095A4 (en) * | 2010-08-27 | 2014-06-18 | Calcimedica Inc | COMPOUNDS MODULATING INTRACELLULAR CALCIUM |
| CN103619171B (zh) | 2010-11-03 | 2015-11-25 | 陶氏益农公司 | 杀虫组合物和与其相关的方法 |
| CN102532123B (zh) * | 2010-12-29 | 2016-03-09 | 中国医学科学院药物研究所 | 噻唑-5-甲酰胺化合物、及其制法和药物组合物与用途 |
| UA112539C2 (uk) * | 2011-03-03 | 2016-09-26 | Новартіс Аг | Спосіб одержання похідних 2-карбоксамідциклоаміносечовини |
| JPWO2012121168A1 (ja) * | 2011-03-04 | 2014-07-17 | 国立大学法人京都大学 | キナーゼ阻害剤 |
| US9255072B2 (en) * | 2011-03-04 | 2016-02-09 | National Health Rsearch Institutes | Pyrazole compounds and thiazole compounds as protein kinases inhibitors |
| CA2834928C (en) * | 2011-05-03 | 2017-10-17 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| US20120316182A1 (en) | 2011-06-10 | 2012-12-13 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| CN103058949A (zh) * | 2011-10-18 | 2013-04-24 | 华东理工大学 | 做为dhodh抑制剂的噻唑衍生物及其应用 |
| WO2013059677A1 (en) | 2011-10-19 | 2013-04-25 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| JP6027128B2 (ja) | 2011-10-26 | 2016-11-16 | ダウ アグロサイエンシィズ エルエルシー | 有害生物防除組成物およびそれに関連した方法 |
| WO2013146754A1 (ja) * | 2012-03-27 | 2013-10-03 | 塩野義製薬株式会社 | Ｔｒｐｖ４阻害活性を有する芳香族複素５員環誘導体 |
| US9282739B2 (en) | 2012-04-27 | 2016-03-15 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| US9708288B2 (en) | 2012-04-27 | 2017-07-18 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| CN104822266B (zh) | 2012-04-27 | 2017-12-05 | 陶氏益农公司 | 杀虫组合物和与其相关的方法 |
| SG11201407919WA (en) * | 2012-05-31 | 2014-12-30 | Phenex Pharmaceuticals Ag | Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ror[gamma] |
| US9512116B2 (en) | 2012-10-12 | 2016-12-06 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
| EP2746260A1 (en) | 2012-12-21 | 2014-06-25 | Basf Se | Substituted [1,2,4]triazole and imidazole compounds |
| EP2746259A1 (en) | 2012-12-21 | 2014-06-25 | Basf Se | Substituted [1,2,4]triazole and imidazole compounds |
| AR094412A1 (es) | 2013-01-10 | 2015-07-29 | Gruenenthal Gmbh | Carboxamidas basadas en pirazolilo i |
| KR20150103752A (ko) | 2013-01-10 | 2015-09-11 | 그뤼넨탈 게엠베하 | Crac 채널 억제제로서의 피라졸릴계 카복스아미드 ⅱ |
| US20160024098A1 (en) | 2013-03-15 | 2016-01-28 | President And Fellows Of Harvard College | Hybrid necroptosis inhibitors |
| AR096788A1 (es) | 2013-07-02 | 2016-02-03 | Bristol Myers Squibb Co | Compuestos tricíclicos de carboxamida como inhibidores potentes de rock |
| WO2015002926A1 (en) | 2013-07-02 | 2015-01-08 | Bristol-Myers Squibb Company | Tricyclic pyrido-carboxamide derivatives as rock inhibitors |
| EP2848615A1 (en) | 2013-07-03 | 2015-03-18 | Almirall, S.A. | New pyrazole derivatives as CRAC channel modulators |
| WO2015058022A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| CN105636440A (zh) | 2013-10-17 | 2016-06-01 | 美国陶氏益农公司 | 制备杀虫化合物的方法 |
| WO2015058028A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| US9174962B2 (en) | 2013-10-17 | 2015-11-03 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| US9085564B2 (en) | 2013-10-17 | 2015-07-21 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| WO2015058024A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| JP2016536295A (ja) | 2013-10-17 | 2016-11-24 | ダウ アグロサイエンシィズ エルエルシー | 有害生物防除性化合物の製造方法 |
| TW201519779A (zh) | 2013-10-22 | 2015-06-01 | Dow Agrosciences Llc | 協同性殺蟲組成物及相關方法（十二） |
| RU2016119560A (ru) | 2013-10-22 | 2017-11-28 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Синергетические пестицидные композиции и относящиеся к ним способы |
| TW201519786A (zh) | 2013-10-22 | 2015-06-01 | 陶氏農業科學公司 | 殺蟲組成物及相關方法（一） |
| US9788545B2 (en) | 2013-10-22 | 2017-10-17 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| KR20160074635A (ko) | 2013-10-22 | 2016-06-28 | 다우 아그로사이언시즈 엘엘씨 | 상승작용적 살충 조성물 및 관련 방법 |
| US9282740B2 (en) | 2013-10-22 | 2016-03-15 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| JP2016536307A (ja) | 2013-10-22 | 2016-11-24 | ダウ アグロサイエンシィズ エルエルシー | 農薬組成物および関連する方法 |
| AU2014340437B2 (en) | 2013-10-22 | 2017-09-07 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| MX2016005317A (es) | 2013-10-22 | 2016-08-12 | Dow Agrosciences Llc | Composiciones pesticidas y metodos relacionados. |
| TW201519771A (zh) | 2013-10-22 | 2015-06-01 | Dow Agrosciences Llc | 協同性殺蟲組成物及相關方法（三） |
| TW201517797A (zh) | 2013-10-22 | 2015-05-16 | Dow Agrosciences Llc | 協同性殺蟲組成物及相關方法（十一） |
| JP2016538266A (ja) | 2013-10-22 | 2016-12-08 | ダウ アグロサイエンシィズ エルエルシー | 相乗的有害生物防除組成物および関連する方法 |
| MX385974B (es) | 2013-10-22 | 2025-03-18 | Corteva Agriscience Llc | Composiciones pesticidas y métodos relacionados. |
| KR20160074640A (ko) | 2013-10-22 | 2016-06-28 | 다우 아그로사이언시즈 엘엘씨 | 살충 조성물 및 관련 방법 |
| KR20160074633A (ko) | 2013-10-22 | 2016-06-28 | 다우 아그로사이언시즈 엘엘씨 | 상승작용적 살충 조성물 및 관련 방법 |
| MX2016005304A (es) | 2013-10-22 | 2017-03-01 | Dow Agrosciences Llc | Composiciones pesticidas sinergicas y metodos relacionados. |
| CN105828608A (zh) | 2013-10-22 | 2016-08-03 | 美国陶氏益农公司 | 杀虫组合物和与其相关的方法 |
| JP6327841B2 (ja) * | 2013-12-06 | 2018-05-23 | 住友精化株式会社 | 芳香族チアゾール化合物の製造方法 |
| WO2015197187A1 (en) | 2014-06-24 | 2015-12-30 | Grünenthal GmbH | Pyrazolyl-based carboxamides v |
| BR112017000565A2 (pt) | 2014-07-31 | 2017-11-07 | Dow Agrosciences Llc | processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina |
| EP3174856A4 (en) | 2014-07-31 | 2018-01-10 | Dow AgroSciences LLC | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine |
| JP2017523168A (ja) | 2014-07-31 | 2017-08-17 | ダウ アグロサイエンシィズ エルエルシー | ３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの製造方法 |
| EP3183238A4 (en) | 2014-08-19 | 2018-01-10 | Dow AgroSciences LLC | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine |
| BR112017004613A2 (pt) | 2014-09-12 | 2017-12-05 | Dow Agrosciences Llc | processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina |
| TWI705057B (zh) | 2014-10-30 | 2020-09-21 | 比利時商健生藥品公司 | 用作ＲＯＲγｔ調節劑之三氟甲基醇 |
| HRP20200016T1 (hr) | 2014-10-30 | 2020-03-20 | Janssen Pharmaceutica Nv | Amidno supstituirani tiazoli kao modulatori rorgamat |
| EP3212641B1 (en) | 2014-10-30 | 2018-12-05 | Janssen Pharmaceutica NV | Thiazoles as modulators of roryt |
| EP3778595B1 (en) | 2015-02-27 | 2021-08-25 | Calcimedica, Inc. | Pancreatitis treatment |
| WO2016183173A1 (en) * | 2015-05-12 | 2016-11-17 | Avista Pharma Solutions | Antiparasitic compounds |
| CA2995094A1 (en) | 2015-08-07 | 2017-02-16 | Calcimedica, Inc. | Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury |
| WO2017109793A1 (en) * | 2015-12-21 | 2017-06-29 | Council Of Scientific & Industrial Research | Novel 1,2,3 triazole-thiazole compounds, process for preparation and use thereof |
| KR101857714B1 (ko) * | 2016-02-05 | 2018-05-15 | 연세대학교 산학협력단 | 신규 아미드 화합물 및 이의 용도 |
| JP2019513762A (ja) * | 2016-04-11 | 2019-05-30 | ジェンフィＧｅｎｆｉｔ | 胆汁うっ滞及び線維症の処置方法 |
| JP6894923B2 (ja) | 2016-04-11 | 2021-06-30 | ジェンフィＧｅｎｆｉｔ | 胆汁うっ滞性及び線維性の疾患の処置方法 |
| TW201803869A (zh) | 2016-04-27 | 2018-02-01 | 健生藥品公司 | 作為ＲＯＲγＴ調節劑之６－胺基吡啶－３－基噻唑 |
| CN105943535B (zh) * | 2016-05-23 | 2017-05-31 | 泉州市景江电子科技有限公司 | 一种治疗乙肝的药物组合物 |
| CN110325036B (zh) | 2016-12-29 | 2021-10-26 | 美国陶氏益农公司 | 用于制备杀虫化合物的方法 |
| WO2018125815A1 (en) | 2016-12-29 | 2018-07-05 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| CN107400124A (zh) * | 2017-09-14 | 2017-11-28 | 刘双伟 | 一种烟酰胺类化合物、合成路线及其在制备抗过敏药物中的应用 |
| CN107501258B8 (zh) * | 2017-09-14 | 2018-10-16 | 青岛大学附属医院 | 一种噻唑基烟酰胺类化合物及其在制备抗过敏和哮喘药物中的应用 |
| JP2021528405A (ja) | 2018-06-18 | 2021-10-21 | ヤンセン ファーマシューティカ エヌ．ベー． | ＲＯＲγｔのモジュレータとしてのアミド置換チアゾール |
| JP2021528398A (ja) | 2018-06-18 | 2021-10-21 | ヤンセン ファーマシューティカ エヌ．ベー． | ＲＯＲγＴのモジュレーターとしての６−アミノピリジン−３−イルピラゾール |
| ES2929140T3 (es) | 2018-06-18 | 2022-11-25 | Janssen Pharmaceutica Nv | Imidazoles sustituidos con fenilo y piridinilo como moduladores de RORgammat |
| EP3807261B1 (en) | 2018-06-18 | 2022-07-13 | Janssen Pharmaceutica NV | Pyridinyl pyrazoles as modulators of roryt |
| WO2020053834A1 (en) | 2018-09-14 | 2020-03-19 | Rhizen Pharmaceuticals Sa | Compositions comprising a crac inhibitor and a corticosteroid and methods of use thereof |
| KR102732033B1 (ko) | 2019-07-26 | 2024-11-20 | 아주대학교산학협력단 | Tlr7 및 tlr9의 신호전달 경로를 억제하는 신규한 소분자 화합물 및 그 용도 |
| AR120896A1 (es) * | 2019-12-25 | 2022-03-30 | Astellas Pharma Inc | COMPUESTO DE PIRIDAZINIL-TIAZOLCARBOXAMIDA COMO INHIBIDORES DE DGKz |
| TWI885039B (zh) | 2020-01-13 | 2025-06-01 | 美商邊際分析公司 | 經取代吡唑并嘧啶及其用途 |
| JP2023528537A (ja) | 2020-03-20 | 2023-07-04 | カルシメディカ，インク． | 急性肺傷害及び急性呼吸窮迫症候群を処置するための方法及び組成物 |
| CA3198798A1 (en) | 2020-11-13 | 2022-05-19 | Kenneth Stauderman | Improved synthesis of crac channel inhibitors |
| CR20230415A (es) * | 2020-11-30 | 2023-09-08 | Kotobuki Pharmaceutical Co Ltd | Compuesto de heteroarilcarboxamida |
| CN116199682B (zh) * | 2023-03-17 | 2025-04-22 | 凯思凯迪（上海）医药科技有限公司 | 一种苯基噻唑基苯甲酰胺类化合物及其应用 |
| KR20250144817A (ko) * | 2024-03-27 | 2025-10-13 | 동국대학교 산학협력단 | 신규 옥사다이아졸 유도체 및 이를 포함하는 암 예방 또는 치료용 조성물 |
| CN118415982B (zh) * | 2024-04-15 | 2024-12-10 | 山东京卫制药有限公司 | 一种硝酸2-（4-甲基噻唑-5-基）乙酯盐酸盐鼻喷剂及其制备方法 |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) * | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3794636A (en) * | 1971-09-03 | 1974-02-26 | Uniroyal Ltd | Process for preparation of thiazole hydrohalides |
| US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| GR65893B (https=) | 1976-02-09 | 1980-12-01 | Lilly Co Eli | |
| US4141984A (en) * | 1976-11-10 | 1979-02-27 | Eli Lilly And Company | N-(1,3,4-thiadiazol-2-yl)benzamides |
| DD138903A1 (de) | 1978-08-25 | 1979-11-28 | Hans U Kibbel | Verfahren zur herstellung von 4-alkylmercapto-2-aryl-5-aryliden-imino-thiazolen |
| DD222022A1 (de) | 1984-02-27 | 1985-05-08 | Pieck Uni Rostock W | Verfahren zur herstellung von alkylammonium 2-aryl-5-benzyliden-aminothiazol-4-thiolaten |
| IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| JPH0228175A (ja) | 1987-12-14 | 1990-01-30 | Sawai Seiyaku Kk | チアゾール環およびテトラゾール環を有するカルボキシアミド誘導体およびその用途 |
| EP0321115B1 (en) * | 1987-12-14 | 1991-08-14 | Sawai Pharmaceutical Co., Ltd. | Carboxamide derivatives having tetrazole and thiazole rings and their use |
| US5073543A (en) * | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) * | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5244867A (en) * | 1989-09-26 | 1993-09-14 | Basf Aktiengesellschaft | Oxazole- and thiazolecarboxamides |
| US5120548A (en) * | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) * | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| FR2677356B1 (fr) * | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
| US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5591767A (en) * | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| AU7551894A (en) | 1993-09-09 | 1995-03-27 | E.I. Du Pont De Nemours And Company | Fungicidal, miticidal and arthropodicidal aminopyrimidines |
| JPH07149746A (ja) | 1993-11-30 | 1995-06-13 | Hisamitsu Pharmaceut Co Inc | 新規な２−置換アミノチアゾール誘導体 |
| IT1270594B (it) * | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| AU3201095A (en) * | 1994-07-27 | 1996-02-22 | G.D. Searle & Co. | Substituted thiazoles for the treatment of inflammation |
| US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| MY128323A (en) * | 1996-09-30 | 2007-01-31 | Otsuka Pharma Co Ltd | Thiazole derivatives for inhibition of cytokine production and of cell adhesion |
| US6399656B1 (en) * | 1998-07-28 | 2002-06-04 | Smithkline Beecham Corporation | Compounds and methods |
| US6492400B1 (en) * | 1998-12-18 | 2002-12-10 | Bristol-Myers Squibb Pharma Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| CN1376150A (zh) * | 1999-07-26 | 2002-10-23 | 盐野义制药株式会社 | 具有血栓形成素受体拮抗作用的药物组合物 |
| WO2001074811A2 (en) * | 2000-03-30 | 2001-10-11 | Takeda Chemical Industries, Ltd. | Substituted 1,3-thiazole compounds, their production and use |
| JP2002302488A (ja) * | 2000-03-30 | 2002-10-18 | Takeda Chem Ind Ltd | 置換１，３−チアゾール化合物、その製造法および用途 |
| JP4880816B2 (ja) | 2000-12-15 | 2012-02-22 | 株式会社ヤクルト本社 | 皮膚老化防止剤 |
| JP4224566B2 (ja) * | 2000-12-18 | 2009-02-18 | 株式会社医薬分子設計研究所 | 炎症性サイトカイン産生遊離抑制剤 |
| JP2002302458A (ja) | 2000-12-26 | 2002-10-18 | Takeda Chem Ind Ltd | 併用薬 |
| WO2002051442A1 (en) * | 2000-12-26 | 2002-07-04 | Takeda Chemical Industries, Ltd. | Concomitant drugs |
| US7199124B2 (en) | 2001-02-02 | 2007-04-03 | Takeda Pharmaceutical Company Limited | JNK inhibitor |
| JP2002302445A (ja) | 2001-02-02 | 2002-10-18 | Takeda Chem Ind Ltd | Ｊｎｋ阻害剤 |
| US20040242637A1 (en) | 2001-08-17 | 2004-12-02 | Hartman George D | Tyrosine kinase inhibitors |
| US7259175B2 (en) * | 2002-02-25 | 2007-08-21 | Eli Lilly And Company | Peroxisome proliferator activated receptor modulators |
| EP1512396A4 (en) * | 2002-06-05 | 2008-12-31 | Inst Med Molecular Design Inc | HEMMER AGAINST ACTIVATION OF AP-1 AND NFAT |
| US20040110802A1 (en) | 2002-08-23 | 2004-06-10 | Atli Thorarensen | Antibacterial benzoic acid derivatives |
| US6737382B1 (en) * | 2002-10-23 | 2004-05-18 | Nippon Soda Co. Ltd. | Insecticidal aminothiazole derivatives |
| CA2505322A1 (en) | 2002-11-08 | 2004-05-21 | Takeda Pharmaceutical Company Limited | Receptor function regulator |
| US7273866B2 (en) * | 2002-12-20 | 2007-09-25 | Bristol-Myers Squibb Company | 2-aryl thiazole derivatives as KCNQ modulators |
| US6987118B2 (en) * | 2003-05-21 | 2006-01-17 | Pfizer Inc. | Tetrahydroisoquinoline derivatives as PPAR-alpha activators |
| WO2005002673A1 (en) | 2003-07-03 | 2005-01-13 | Astex Therapeutics Limited | Raf kinase inhibitors |
| JPWO2005007151A1 (ja) | 2003-07-16 | 2006-08-31 | 株式会社医薬分子設計研究所 | 皮膚色素沈着の治療剤 |
| TWI376370B (en) * | 2003-07-23 | 2012-11-11 | Synta Pharmaceuticals Corp | Compounds for inflammation and immune-related uses |
| US20050107438A1 (en) * | 2003-09-03 | 2005-05-19 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition comprising 3-[(2-{[4-(Hexyloxycarbonylaminoiminomethyl) phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester or a salt therefore |
| ZA200602755B (en) * | 2003-09-06 | 2007-06-27 | Vertex Pharma | Modulators of ATP-binding cassette transporters |
| CN1863535A (zh) * | 2003-10-08 | 2006-11-15 | 明治制果株式会社 | 含有头孢托仑匹伏酯的非晶性抗菌组合物 |
| WO2005044194A2 (en) | 2003-10-28 | 2005-05-19 | Pharmacia Corporation | TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR |
| JP4638355B2 (ja) | 2003-12-26 | 2011-02-23 | 協和発酵キリン株式会社 | チアゾール誘導体 |
| WO2005091752A2 (en) * | 2004-03-25 | 2005-10-06 | Synta Pharmaceuticals Corp. | Acrylonitrile derivatives for inflammation and immune-related uses |
| WO2006066174A1 (en) | 2004-12-17 | 2006-06-22 | Eli Lilly And Company | Thiazolopyridinone derivates as mch receptor antagonists |
| WO2006125807A1 (en) | 2005-05-24 | 2006-11-30 | Laboratoires Serono S.A. | Thiazole derivatives and use thereof |
| TW200806641A (en) * | 2006-01-25 | 2008-02-01 | Synta Pharmaceuticals Corp | Substituted aromatic compounds for inflammation and immune-related uses |
| WO2007087429A2 (en) * | 2006-01-25 | 2007-08-02 | Synta Pharmaceuticals Corp. | Phenyl and pyridyl compounds for inflammation and immune-related uses |
| TW200806290A (en) * | 2006-01-25 | 2008-02-01 | Synta Pharmaceuticals Corp | Substituted biaryl compounds for inflammation and immune-related uses |
| US7816535B2 (en) * | 2006-01-25 | 2010-10-19 | Synta Pharmaceuticals Corp. | Vinyl-phenyl derivatives for inflammation and immune-related uses |
-
2007
- 2007-01-25 US US11/698,772 patent/US8455658B2/en not_active Expired - Fee Related
- 2007-01-25 AU AU2007208225A patent/AU2007208225B2/en not_active Ceased
- 2007-01-25 EP EP07717039A patent/EP1983980A4/en not_active Withdrawn
- 2007-01-25 CA CA002639910A patent/CA2639910A1/en not_active Abandoned
- 2007-01-25 JP JP2008552423A patent/JP2009524677A/ja active Pending
- 2007-01-25 WO PCT/US2007/002121 patent/WO2007087427A2/en not_active Ceased
- 2007-01-25 TW TW096102794A patent/TWI444370B/zh not_active IP Right Cessation
-
2013
- 2013-05-16 US US13/895,590 patent/US20140135331A9/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009524677A5 (https=) | ||
| JP2008526866A5 (https=) | ||
| JP2009525285A5 (https=) | ||
| JP2006506340A5 (https=) | ||
| DK2038265T3 (en) | Inhibitors of human protein tyrosine phosphatase and methods of use | |
| IL303196A (en) | Heteroaryl-substituted pyridines and methods of use | |
| AU2007208225B2 (en) | Thiazole and thiadiazole compounds for inflammation and immune-related uses | |
| JP2009524683A5 (https=) | ||
| WO2012047966A4 (en) | Compositions and methods for treating ocular edema, neovascularization and related diseases | |
| RU2005129729A (ru) | Производные гетероарилкарбамоилбензола | |
| JP2008501673A5 (https=) | ||
| JP2009513563A5 (https=) | ||
| RU2011133833A (ru) | Способы лечения синдрома сосудистой утечки | |
| JP2019517455A5 (https=) | ||
| JP2006077019A5 (https=) | ||
| JP2007523142A5 (https=) | ||
| HRP20110825T1 (hr) | Derivati aminotriazola kao alx agonisti | |
| JP2009529059A5 (https=) | ||
| JP2013530240A5 (https=) | ||
| JP2007519735A5 (https=) | ||
| RU2009102516A (ru) | Ингибиторы протеинтирозинфосфатазы человека и способы их использования | |
| JP2015517580A5 (https=) | ||
| JP2009542659A5 (https=) | ||
| US20130023542A1 (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
| JP2010540462A5 (https=) |